Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 706M | 730M | 708M | 728M |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 94M | — | 75M | 73M |
| Other operating expenses | 0 | 225M | 2M | 2M |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 382M | 440M | 433M | 452M |
| Tax provision | 100M | — | 114M | 121M |
| Net income | 282M | 184M | 318M | 331M |
| Basic EPS | 0.2 | 0.1 | 0.3 | 0.3 |
| Diluted EPS | 0.2 | 0.1 | 0.3 | 0.3 |
| Basic average shares | 1.2B | 1.2B | 1.2B | 1.2B |
| Diluted average shares | 1.2B | 1.2B | 1.2B | 1.2B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 382M | 226M | 433M | 452M |
| Minority interests | 2M | — | 0 | -1M |
| Preferred stock dividends | — | 13M | — | — |